摘要
科技人才、经费投入、相关产业发展水平及政府引导措施等因素会对一个国家新药研发能力产生重要影响。美国是全球新药研发能力最强的国家,上述因素在促进美国新药研发能力提高上发挥了重要作用。本文通过对美、中2国新药创新体系中上述重要因素的深入对比分析,对如何采取相应措施增强我国新药研发能力进行了探讨。
Scientific and technical talents, outlay for research and development （R＆D）, comparative equivalent development of the relative industries as well as government guidance etc will have an important impact on the capacity of pharmaceutical R＆D in a country. The capacity of pharmaceutical R＆D in U.S.A is the strongest in the world, the forementioned factors also play an important role in that field. The authors analyzed and comprised the key factors related with the innovative system of new drug in the U.S.A and China; and provide enhanced correlative managements for our new drug research and development capabilities.
出处
《中国新药与临床杂志》
CAS
CSCD
北大核心
2008年第10期795-800,共6页
Chinese Journal of New Drugs and Clinical Remedies
关键词
药物批准
知识产权
组织管理
制药工业
drug approval
intellectual property
organization and administration
drug industry
